Roberto Mignone
Director · Guardant Health, Inc.
IndividualSelling only
- 2024
- Sep 22, 2026
- 21
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Roberto Mignone files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Amirali Talasaz - $73.75M in GH purchases and sales in the last 12 months
- Richard D. Francis - $31.26M in TEVA purchases and sales in the last 12 months
- Eliyahu Sharon Kalif - $20.73M in TEVA purchases and sales in the last 12 months
- Terilyn J. Monroe - $14.82M in GH purchases and sales in the last 12 months
- Chris Freeman - $13.68M in GH purchases and sales in the last 12 months
- Mark Sabag - $13.15M in TEVA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Roberto Mignone?
Roberto Mignone is a corporate insider, tracked as Director of Guardant Health, Inc. (GH). InsiderAlpha holds 21 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Roberto Mignone submitted recently?
4 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Roberto Mignone been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($29.11M) across all tracked filings.
